254 related articles for article (PubMed ID: 26109640)
1. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.
Mulrooney TJ; Zhang AC; Goldgur Y; Boudreau JE; Hsu KC
J Immunol; 2015 Aug; 195(3):1242-50. PubMed ID: 26109640
[TBL] [Abstract][Full Text] [Related]
2. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
[TBL] [Abstract][Full Text] [Related]
4. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.
Zipperlen K; Gallant M; Stapleton S; Heath J; Barrett L; Grant M
Immunol Cell Biol; 2015 Jan; 93(1):67-76. PubMed ID: 25112829
[TBL] [Abstract][Full Text] [Related]
5. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.
Tallon BJ; Bruneau J; Tsoukas CM; Routy JP; Kiani Z; Tan X; Bernard NF
PLoS One; 2014; 9(10):e110480. PubMed ID: 25330014
[TBL] [Abstract][Full Text] [Related]
6. Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.
O'Connor GM; Vivian JP; Gostick E; Pymm P; Lafont BA; Price DA; Rossjohn J; Brooks AG; McVicar DW
J Virol; 2015 May; 89(10):5213-21. PubMed ID: 25740999
[TBL] [Abstract][Full Text] [Related]
7. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.
Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C
Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260
[TBL] [Abstract][Full Text] [Related]
8. Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1.
O'Connor GM; Yamada E; Rampersaud A; Thomas R; Carrington M; McVicar DW
J Immunol; 2011 Sep; 187(5):2162-71. PubMed ID: 21804024
[TBL] [Abstract][Full Text] [Related]
9. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.
Norman PJ; Abi-Rached L; Gendzekhadze K; Korbel D; Gleimer M; Rowley D; Bruno D; Carrington CV; Chandanayingyong D; Chang YH; Crespí C; Saruhan-Direskeneli G; Fraser PA; Hameed K; Kamkamidze G; Koram KA; Layrisse Z; Matamoros N; Milà J; Park MH; Pitchappan RM; Ramdath DD; Shiau MY; Stephens HA; Struik S; Verity DH; Vaughan RW; Tyan D; Davis RW; Riley EM; Ronaghi M; Parham P
Nat Genet; 2007 Sep; 39(9):1092-9. PubMed ID: 17694054
[TBL] [Abstract][Full Text] [Related]
10. Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.
Sharma D; Bastard K; Guethlein LA; Norman PJ; Yawata N; Yawata M; Pando M; Thananchai H; Dong T; Rowland-Jones S; Brodsky FM; Parham P
J Immunol; 2009 Oct; 183(7):4569-82. PubMed ID: 19752231
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.
Erer B; Takeuchi M; Ustek D; Tugal-Tutkun I; Seyahi E; Özyazgan Y; Duymaz-Tozkir J; Gül A; Kastner DL; Remmers EF; Ombrello MJ
Genes Immun; 2016 Dec; 17(7):396-399. PubMed ID: 27708262
[TBL] [Abstract][Full Text] [Related]
12. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.
Alter G; Rihn S; Walter K; Nolting A; Martin M; Rosenberg ES; Miller JS; Carrington M; Altfeld M
J Virol; 2009 Jul; 83(13):6798-805. PubMed ID: 19386717
[TBL] [Abstract][Full Text] [Related]
13. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells.
Morvan M; Willem C; Gagne K; Kerdudou N; David G; Sébille V; Folléa G; Bignon JD; Retière C
J Immunol; 2009 Jun; 182(11):6727-35. PubMed ID: 19454667
[TBL] [Abstract][Full Text] [Related]
15. Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.
Prakash S; Sarangi AN; Alam S; Sonawane A; Sharma RK; Agrawal S
Gene; 2017 Dec; 637():219-229. PubMed ID: 28942035
[TBL] [Abstract][Full Text] [Related]
16. Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression.
Grifoni A; Montesano C; Palma P; Salerno A; Colizzi V; Amicosante M
Mol Immunol; 2013 Apr; 53(4):410-3. PubMed ID: 23103378
[TBL] [Abstract][Full Text] [Related]
17. Allele diversity of the killer cell immunoglobulin-like receptors KIR3DL1/S1 and the combination with their HLA ligands in Mexican Mestizos from Mexico City.
González-Quezada BA; Sánchez-Fernández MGJ; Munguía-Saldaña AJ; Valencia-Macedo ME; Flores-Aguilar H; Bonilla-Galán E; Rodríguez-Gómez A; Díaz-Rivera A; Gorodezky C
Hum Immunol; 2018 Dec; 79(12):834-838. PubMed ID: 30365992
[TBL] [Abstract][Full Text] [Related]
18. KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.
Forlenza CJ; Boudreau JE; Zheng J; Le Luduec JB; Chamberlain E; Heller G; Cheung NK; Hsu KC
J Clin Oncol; 2016 Jul; 34(21):2443-51. PubMed ID: 27069083
[TBL] [Abstract][Full Text] [Related]
19. Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.
O'Connor GM; Vivian JP; Widjaja JM; Bridgeman JS; Gostick E; Lafont BA; Anderson SK; Price DA; Brooks AG; Rossjohn J; McVicar DW
J Immunol; 2014 Mar; 192(6):2875-84. PubMed ID: 24563253
[TBL] [Abstract][Full Text] [Related]
20. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.
Sanjanwala B; Draghi M; Norman PJ; Guethlein LA; Parham P
J Immunol; 2008 Nov; 181(9):6293-300. PubMed ID: 18941220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
